Early Diagnosis Campaign Sponsors
The Early Diagnosis Campaign is made possible thanks to the support of the following corporate sponsors.
Actelion Pharmaceuticals US, Inc.
Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs as innovative treatments to serve high unmet medical needs. The company has its corporate headquarters in Allschwil/Basel, Switzerland where it was founded in 1997.
The company has proven its ability to discover new compounds and to rapidly move them from research through development to commercialization. In particular, Actelion scientists were among the first to work in the field of endothelin receptor antagonists.
Actelion has over 30 operative affiliates around the world including the United States, Canada, Brazil, Australia, Japan, Switzerland and a number of EU countries. These subsidiaries provide or will provide distribution, sales and marketing services.
To learn more, visit www.actelion.com.
View Actelion's other 2015 contributions to PHA
Gilead Sciences, Inc.
To learn more, visit www.gilead.com.
View Gilead's other 2015 contributions to PHA
United Therapeutics Corporation
To learn more, visit www.unither.com.
View United Therapeutics's other 2015 contributions to PHA
For more information about opportunities to sponsor the Early Diagnosis Campaign, contact Sponsorships@PHAssociation.org.